-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Chemomab Therapeutics Ltd. quarterly/annual Return On Equity history and change rate from 2019 to Q2 2023.
- Chemomab Therapeutics Ltd. Return On Equity for the quarter ending 30 Jun 2023 was -101 %, a 209% decline year-over-year.
- Chemomab Therapeutics Ltd. annual Return On Equity for 2022 was -58.2 %, a 192% decline from 2021.
- Chemomab Therapeutics Ltd. annual Return On Equity for 2021 was -20 %, a 61% increase from 2020.
- Chemomab Therapeutics Ltd. annual Return On Equity for 2020 was -51.2 %, a 56.9% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)